Du, Yu, et al. “Pembrolizumab Versus High-Dose Interferon-α2b As Adjuvant Therapy for Pediatric Melanoma: A Retrospective Study ”. Dermatology Practical & Conceptual, vol. 14, no. 1, Jan. 2024, p. e2024026, https://doi.org/10.5826/dpc.1401a26.